Immunogenicity and Safety Trial of the HIV-1 Tat Vaccine
Clinical trial NCT00751595 · COMPLETED
Trial details
- NCT number
- NCT00751595
- Sponsor
- Barbara Ensoli, MD
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-09-01
- Primary completion
- 2012-06-01
- Enrollment
- 168
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.